Patents by Inventor Alberto Plaza

Alberto Plaza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • EXOSKELETON COMPRISING A PLURALITY OF AUTONOMOUSLY OPERABLE MODULES
    Publication number: 20220354730
    Abstract: An exoskeleton (1) having a plurality of autonomously operable modules (2RK, 2LK, 2RH, 2LH) each having a dedicated controller (23RK, 23LK, 23RH, 23LH) connected to an actuated joint. The exoskeleton (1) further having a multimaster electrical communicator (3) between the controllers (23RK, 23LK, 23RH, 23LH) of the modules (2RK, 2LK, 2RH, 2LH). The controller (23RK, 23LK, 23RH, 23LH) of each module (2RK, 2LK, 2RH, 2LH) is configured for: collecting information from sensors; sharing information with the remaining modules through the multimaster electrical communicator (3); determining which other modules (2RK, 2LK, 2RH, 2LH) are present; and autonomously calculating and commanding a desired trajectory of the actuated joint of the module (2RK, 2LK, 2RH, 2LH) for assisting the movement of the corresponding biological joint in coordination with the kinematic condition of other biological joints.
    Type: Application
    Filed: April 29, 2022
    Publication date: November 10, 2022
    Inventors: Elena Garcia Armada, Alberto Plaza Flores, Mar Hernandez Melero, Manuel Prieto Perez-Borroto
  • COMFREYNS, ARYLNAPHTHALENE LIGNANS THAT INHIBIT PRO-INFLAMMATORY GENE EXPRESSION, AND PHARMACEUTIC COMPOSITION COMPRISING THEM
    Publication number: 20210269411
    Abstract: The present invention relates to one or more arylnaphthalene lignan(s), in particular, comfreyn A, and a pharmaceutic composition comprising it. Comfreyn A was isolated from a preparation of comfrey (Symphytum officinale L.) roots and was found to reduce inflammation by interfering with pro-inflammatory gene expression. In particular, it inhibited E-selectine expression in interleukin 1? (IL-1?)-induced HUVEC cells.
    Type: Application
    Filed: February 25, 2021
    Publication date: September 2, 2021
    Inventors: Alberto Plaza, Sonia Piacente, Milena Masullo, Gilda D'Urso
  • Chrysophaentin antimicrobial compounds that inhibit FtsZ protein
    Patent number: 8399689
    Abstract: Embodiments of antimicrobial chrysophaentin compounds, pharmaceutical compositions including the chrysophaentin compounds, and methods for using the chrysophaentin compounds are disclosed. Some embodiments of the disclosed compounds are isolated from Chrysophaeum taylori. Certain embodiments of the chrysophaentin compounds inhibit FtsZ protein, thereby inhibiting the growth of clinically relevant bacteria, including drug-resistant strains.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: March 19, 2013
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Carole A. Bewley, Alberto Plaza, Jessica Keffer
  • CHRYSOPHAENTIN ANTIMICROBIAL COMPOUNDS THAT INHIBIT FTSZ PROTEIN
    Publication number: 20120316227
    Abstract: Embodiments of antimicrobial chrysophaentin compounds, pharmaceutical compositions including the chrysophaentin compounds, and methods for using the chrysophaentin compounds are disclosed. Some embodiments of the disclosed compounds are isolated from Chrysophaeum taylori. Certain embodiments of the chrysophaentin compounds inhibit FtsZ protein, thereby inhibiting the growth of clinically relevant bacteria, including drug-resistant strains.
    Type: Application
    Filed: February 25, 2011
    Publication date: December 13, 2012
    Inventors: Carole A. Bewley, Alberto Plaza, Jessica Keffer